NCT00372632View on ClinicalTrials.gov

IPT of Malaria With SP in Different Zones of Drug Resistance in Rwanda

PHASE4CompletedINTERVENTIONAL
Enrollment

1,717

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Non HIV Infected Pregnant Women
Interventions
DRUG

Sulfadoxine-Pyrimethamine

The intervention group receives 1500mg of sulfadoxine and 75mg of pyrimethamine at enrollment and in the third trimester.

DRUG

placebo

The control group receives placebo similar in taste and appearance to to the experimental arm

Trial Locations (1)

Unknown

Programme Nationale de Controle de Paludisms, Kigali

All Listed Sponsors
lead

Institute of Tropical Medicine, Belgium

OTHER

NCT00372632 - IPT of Malaria With SP in Different Zones of Drug Resistance in Rwanda | Biotech Hunter | Biotech Hunter